Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this study is to get a better understanding of the skin condition, Hidradenitis Suppurativa, and to find out how the disease affects quality of life. The investigators hope this information will help improve treatment for this skin condition.
The goal of this study is to get a better understanding of the skin condition, Hidradenitis Suppurativa, and to find out how the disease affects quality of life. The investigators will utilize a compilation of validated questionnaires including the Beck Depression Inventory form, Dermatology Life Quality Index (DLQI), Skindex, SF-36 health survey, the Quality of Life Enjoyment and Satisfaction Questionnaire- short form (Q-LES-Q-SF) and the Employment/Productivity Health Economic Questionnaire as well as other relevant clinical data. The investigators will additionally collect a modified Hidradenitis Suppurativa Lesion, Area, and Severity Index (HS-LASI) (or other appropriate disease severity score as determined by the team) from the physician of each enrollee. The investigators hope this information will help improve treatment for this skin condition.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hidradenitis Suppurativa Cohort | Patients with Hidradenitis Suppurativa (ages 18-99 years old) will be asked to complete a series of questionnaires on how Hidradenitis Suppurativa impacts quality of life. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Skin-related quality of life | Quality of life as measured using standardized Dermatology Quality of Life Index | Baseline |
| Presence and severity of depression | Presence and severity of depression as measured using standardized Beck Depression Inventory | Baseline |
| Skin-related of life | Quality of life as measured using standardized SkinDex questionnaires | Baseline |
| Subject-reported subject health | Subject-reported subject health as measured using the standardized SF-36 questionnaires | Baseline |
| Degree of enjoyment and satisfaction experienced by subjects in daily functioning. | Degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning as measured by the standardized Quality of Life Enjoyment and Satisfaction Questionnaire-short form. | Baseline |
| Employment and economic productivity | Self-reported employment and economic productivity as measured by a standardized health economic questionnaire | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Change in quality of life | Change in quality of life as measured using standardized Dermatology Quality of Life Index after treatment initiation | At 6 months |
| Change in presence and severity of depression |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Healthy adults (ages 18-99) with a diagnosis of Hidradenitis Suppurativa
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Steven R Cohen, MD, MPH | Albert Einstein College of Medicine Montefiore Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Montefiore Medical Center | The Bronx | New York | 10467 | United States |
Not provided
| Label | URL |
|---|---|
| Montefiore Hidradenitis Suppurativa Multispecialty Treatment Center | View source |
Not provided
There is no plan to share individual participant data to other researchers
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D017497 | Hidradenitis Suppurativa |
| ID | Term |
|---|---|
| D017192 | Skin Diseases, Bacterial |
| D001424 | Bacterial Infections |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Change in presence and severity of depression as measured using standardized Beck Depression Inventory after treatment initiation
| At 6 months |
| Change in quality of life | Change in quality of life as measured using standardized SkinDex questionnaires after treatment initiation | At 6 months |
| Change in subject-reported subject health | Change in subject-reported subject health as measured using standardized SF-36 questionnaires after treatment initiation | At 6 months |
| Change in degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning | Change in degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning as measured by the standardized Quality of Life Enjoyment and Satisfaction Questionnaire-short form after treatment initiation | At 6 months |
| Change in self-reported employment and economic productivity | Change in self-reported employment and economic productivity as measured by a standardized health economic questionnaire after treatment initiation | At 6 months |
| D012874 | Skin Diseases, Infectious |
| D013492 | Suppuration |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D016575 | Hidradenitis |
| D013543 | Sweat Gland Diseases |